MC
Insider selling
Mark C. Schneyer sold $69K of ACAD stock
Mark C. Schneyer, EVP, Chief Financial Officer of Acadia Pharmaceuticals Inc (ACAD), sold 3,321 shares of ACAD stock worth $69K, per an SEC Form 4 filed Oct 31, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 15, 2026, 16 days before it was made public.
ACAD has moved +4.5% since the trade date, from $19.71 to $20.59 (Oct 30, 2026 close).
- Traded
- Oct 15, 2026
- Disclosed
- Oct 31, 2026
- Filing delay
- 16 days
- Price since
- +4.5%
- Role
- EVP, Chief Financial Officer
- Source
- SEC Form 4
More ACAD insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.